NCT04201067View on ClinicalTrials.gov

Large-Scale Metabolomic Profiling for the Diagnosis of Inborn Errors of Metabolism

CompletedOBSERVATIONAL
Enrollment

240

Participants

Timeline

Start Date

October 8, 2019

Primary Completion Date

March 12, 2025

Study Completion Date

March 12, 2025

Conditions
Congenital Disorders of Glycosylation
Trial Locations (1)

55905

Mayo Clinic in Rochester, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
collaborator

National Institute of Neurological Disorders and Stroke (NINDS)

NIH

lead

Mayo Clinic

OTHER

NCT04201067 - Large-Scale Metabolomic Profiling for the Diagnosis of Inborn Errors of Metabolism | Biotech Hunter | Biotech Hunter